Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.

OBJECTIVE To examine depression and 3-year change in insulin resistance and risk of diabetes and whether associations vary by race. RESEARCH DESIGN AND METHODS We analyzed data from 2,662 Caucasian, African-American, Hispanic, Japanese-American, and Chinese-American women without a history of diabetes from the Study of Women's Health Across the Nation. We estimated regression coefficients and odds ratios to determine whether depression (Center for Epidemiological Studies Depression Scale score > or =16) predicted increases in homeostasis model assessment of insulin resistance (HOMA-IR) and greater risk of incident diabetes, respectively, over 3 years. RESULTS Mean baseline HOMA-IR was 1.31 (SD 0.86) and increased 0.05 units per year for all women (P <0.0001). A total of 97 incident cases of diabetes occurred. Depression was associated with absolute levels of HOMA-IR (P <0.04) but was unrelated to changes in HOMA-IR; associations did not vary by race. The association between depression and HOMA-IR was eliminated after adjustment for central adiposity (P=0.85). Depression predicted a 1.66-fold greater risk of diabetes (P <0.03), which became nonsignificant after adjustment for central adiposity (P=0.12). We also observed a depression-by-race interaction (P <0.05) in analyses limited to Caucasians and African Americans, the only groups with enough diabetes cases to reliably test this interaction. Race-stratified models showed that depression predicted 2.56-fold greater risk of diabetes in African Americans only, after risk factor adjustment (P=0.008). CONCLUSIONS Depression is associated with higher HOMA-IR values and incident diabetes in middle-aged women. These associations are mediated largely through central adiposity. However, African-American women with depression experience increased risk of diabetes independent of central adiposity and other risk factors.

[1]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[2]  D. Ford,et al.  Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. , 2004, Diabetes care.

[3]  D. Lawlor,et al.  Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study , 2003, BMJ : British Medical Journal.

[4]  M. Carnethon,et al.  Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-up Study, 1971-1992. , 2003, American journal of epidemiology.

[5]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[6]  D. Tate,et al.  The role of adherence in mediating the relationship between depression and health outcomes. , 2002, Journal of psychosomatic research.

[7]  N. Sattar,et al.  C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. , 2002, Diabetes.

[8]  M. Irwin Psychoneuroimmunology of Depression: Clinical Implications , 2002, Brain, Behavior, and Immunity.

[9]  K. Frayn Adipose tissue and the insulin resistance syndrome , 2001, Proceedings of the Nutrition Society.

[10]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[11]  M. de Groot,et al.  Depression among African-Americans with diabetes: a dearth of studies. , 2001, Diabetes care.

[12]  M. Hongo,et al.  Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. , 2000, Metabolism: clinical and experimental.

[13]  A. Nouwen,et al.  A review of the relationship between depression and diabetes in adults: is there a link? , 2000, Diabetes care.

[14]  M. Hongo,et al.  Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. , 2000, Metabolism: clinical and experimental.

[15]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[16]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[17]  K. Davidson,et al.  Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study? Coronary Artery Risk Development in Young Adults. , 2000, Archives of internal medicine.

[18]  H. Shimizu,et al.  Depressive symptoms and occurrence of type 2 diabetes among Japanese men. , 1999, Diabetes care.

[19]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[20]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[21]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[22]  D. Ford,et al.  Depression and Risk for Onset of Type II Diabetes: A prospective population-based study , 1996, Diabetes Care.

[23]  N. Kalin,et al.  Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[24]  P. Remington,et al.  Depression and the dynamics of smoking. A national perspective. , 1990, JAMA.

[25]  Y. Ying,et al.  Depressive symptomatology among Chinese-Americans as measured by the CES-D. , 1988, Journal of clinical psychology.

[26]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[27]  J E Frijters,et al.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.

[28]  M. Weissman,et al.  Use of a self-report symptom scale to detect depression in a community sample. , 1980, The American journal of psychiatry.

[29]  Robert E. Roberts,et al.  Reliability of the CES-D scale in different ethnic contexts , 1980, Psychiatry Research.

[30]  L. Radloff The CES-D Scale , 1977 .

[31]  L. Shulman Racial/Ethnic Differences in the Prevalence of Depressive Symptoms Among Middle-Aged Women: The Study of Women's Health Across the Nation (SWAN) , 2006 .

[32]  J. Manson,et al.  Depressive symptoms and risk of type 2 diabetes in women. , 2004, Diabetes care.

[33]  M. Davidson The disproportionate burden of diabetes in African-American and Hispanic populations. , 2001, Ethnicity & disease.

[34]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.

[35]  David Morganstein,et al.  SWAN: A Multicenter, Multiethnic, Community-Based Cohort Study of Women and the Menopausal Transition , 2000 .

[36]  R. Angel,et al.  The factor structure of the CES-D in the Hispanic Health and Nutrition Examination Survey: the influences of ethnicity, gender and language. , 1989, Social science & medicine.

[37]  G. Sergi,et al.  Visceral obesity and diabetes. , 1988, Hormone and metabolic research. Supplement series.